Galantamine Hydrobromide Nootropic Pharmaceutical for Brain Improve

Galantamine Hydrobromide
Galantamine Hydrobromide CAS: 1953-04-4
Galantamine Hydrobromide MF: C17H22BrNO3
Galantamine Hydrobromide MW: 368.27
Galantamine Hydrobromide EINECS: 217-780-5
MP 256 °C
Storage temp. −20°C
Chemical Properties White to Off-White Powder
Usage A selective acetylcholinesterase inhibitor. A therapeutic agent for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism. galantamine nootropic
Usage Alzheimer treatment;Cholinesterase inhibitor
Usage anticholinesterase, analgesic, antiAlzheimer
Clinical mainly for the treatment of poliomyelitis (poliomyelitis) sequelae, muscle atrophy and myasthenia gravis. Can also be used for children with cerebral palsy, traumatic sensory dyskinesia, polyneuritis and spinal nerve root inflammation.
Application:
This product is anticholinesterase drugs, a weaker anticholinesterase role, through the blood-brain barrier, so the role of the central nervous system is relatively strong. The obstruction of nerve and muscle conduction recovery, improve the various peripheral neuromuscular disorders paralysis.

The treatment of a wide range of less toxic, more tolerable patients. Clinical mainly for the treatment of poliomyelitis (poliomyelitis) sequelae, muscle atrophy and myasthenia gravis. Can also be used for children with cerebral palsy, traumatic sensory dyskinesia, polyneuritis and spinal nerve root inflammation.